Pharmidex is honored to attend the Society for Medicines Research meeting:
December 4, 2024

"Recent Trends in Medicinal Chemistry and Enabling Technologies"
📅 Thursday, 5 December 2024
📍 Burlington House, Piccadilly, London, W1J 0BQ, UK
👉 https://lnkd.in/gi3anrpG

We are excited to share that our Business Development Manager,
Janette Dalay Robertson, will represent Pharmidex at this prestigious event.
Janette looks forward to engaging with attendees to explore and foster commercial synergies, advancing shared goals and collaboration between your companies, institutions, and
Pharmidex.

If you're attending, be sure to connect with Janette for a discussion about how we can work together to achieve innovative breakthroughs! 🌟

#Pharmidex #MedicinalChemistry #Collaboration #Innovation #Chemistry #Chemicalbiology #Medicinesresearch #Peptides #Oligonucleotides #Drugdiscovery #AI #TPD #RoyalSocietyofChemistry

May 8, 2025
At Pharmidex, we are proud to contribute to scientific innovation through robust and reliable bioanalytical support from early discovery to regulated studies. For over eight years, we've partnered with Shimadzu, using their LCMS-8060 and LC-2050 systems to deliver high-quality, data-driven results tailored to diverse client needs. Their instruments have played a key role in advancing our bioanalytical capabilities and supporting the success of our collaborative projects. Our Head of Operations, Ash Alavijeh , recently shared insights from our long-standing collaboration as part of Shimadzu’s 150th anniversary testimonial series. We are honored to be part of their journey and look forward to continuing this partnership built on shared values of precision, reliability, and innovation. 👉 Read more stories from the Shimadzu global community here .
May 7, 2025
At Pharmidex, we stand in solidarity with individuals and families affected by Huntington’s Disease a rare, inherited neurodegenerative condition that impacts the mind, body, and spirit. Throughout May, we reaffirm our commitment to advancing neuroscience research and supporting drug discovery efforts aimed at neurodegenerative diseases. Our team is proud to collaborate with partners working toward meaningful therapies that can improve quality of life and bring hope to the HD community. Let’s raise awareness. Let’s drive innovation. Let’s stand together.
C3 Summit London
May 5, 2025
We’re pleased to share that Mo Yaqoob from our Business Development team will be attending the C3 Summit on 8 May 2025 at 8 Northumberland Ave, London. 🔗 https://www.thec3summit.com/london-2025/  Mo is looking forward to meeting fellow attendees, exploring new partnerships, and discussing how we can work together to accelerate the development of innovative drug candidates. If you're attending, don’t hesitate to connect let’s spark the next great collaboration!
More Posts